IP Verse

Nalmefene For Reduction Of Alcohol Consumption In Specific Target Populations

Patent No. EP4223296 (titled "Nalmefene For Reduction Of Alcohol Consumption In Specific Target Populations") was filed by H Lundbeck on Jun 27, 2013. The application was issued on Jan 29, 2025.

Patent Summary

Nalmefene is used to reduce alcohol consumption in patients with alcohol dependence. Use comprises identifying patients who exhibit a high Drinking Risk Level (DRL), defined as pure alcohol consumption >60 g/day for men and >40 g/day for women, and who maintain this DRL throughout a 1-2 week observation period following initial assessment. Nalmefene is administered to these identified patients on an as-needed basis, specifically on days the patient perceives a risk of drinking alcohol, preferably 1-2 hours prior to the anticipated time of consumption. The invention targets patients with alcohol dependence as defined by DSM-IV-TR or DSM-V criteria, specifically those who are not "Early Reducers" during the observation period.

UPC Cases New

Latest UPC cases involving this patent.

Case NumberFiling DatePlaintiffProceeding Type
UPC_CFI_0000903/2026Mar 12, 2026H LundbeckProvisional Measures
UPC_CFI_0001587/2025Nov 14, 2025BiogaranRevocation

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BIOGARANOct 29, 2025CASALONGA
ALFRED E TIEFENBACHEROct 27, 2025HAMM&WITTKOPP PATENTANWÄLTE PARTMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP4223296

H LUNDBECK
Application Number
EP23163177A
Filing Date
Jun 27, 2013
Status
Granted And Under Opposition
Dec 26, 2024
Publication Date
Jan 29, 2025
External Links
Slate, Register , Google Patents